&nbsp;

Dr. Debra Bournes

Nov 2018

Document

LDCTLungCancerScreeningReportingTemplate.pdf

Jan 2019

Document

LDCTLung-RADSRVersion1.1AssessmentCategories.pdf

Jan 2019

Document

LungCancerScreeningReportingTemplateExplanatoryNotes.pdf

Jan 2019

Regimen

DABRTRAM

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant, Curative

Funding:

Exceptional Access Program

daBRAfenib - For the adjuvant treatment of resected Stage III cutaneous melanoma, based on criteria

Exceptional Access Program

trametinib - For the adjuvant treatment of resected Stage III cutaneous melanoma according to clinical criteria

, Collapse Show fewer tags

Drugs Used:

daBRAFenib,

trametinib

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2025

Document

Defining_Advanced_Practice_in_Radiation_Therapy_A_feasibility_assessment_of_a_new_healthcare_provider_role_in_Ontario

Mar 2019

Regimen

DARA(MNT)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Daratumumab - In Combination with Bortezomib and Dexamethasone for Relapsed Multiple Myeloma

New Drug Funding Program

Daratumumab in Combination with a Bortezomib-Based Regimen for Newly Diagnosed Transplant Ineligible Multiple Myeloma